-
Signature
-
/s/ Kristie Scott, Attorney-in-Fact
-
Issuer symbol
-
XMTR
-
Transactions as of
-
02 Jul 2025
-
Net transactions value
-
-$302,227
-
Form type
-
4
-
Filing time
-
03 Jul 2025, 16:11:43 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Altschuler Randolph |
Chief Executive Officer, Director |
C/O XOMETRY, INC., 6116 EXECUTIVE BLVD, SUITE 800, NORTH BETHESDA |
/s/ Kristie Scott, Attorney-in-Fact |
03 Jul 2025 |
0001869814 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$290,538 |
-8,978 |
-2.7% |
$32.36 |
319,956 |
02 Jul 2025 |
Direct |
F1, F2, F3 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$11,689 |
-354 |
-0.11% |
$33.02 |
319,602 |
02 Jul 2025 |
Direct |
F1, F2 |
| holding |
XMTR |
Class B Common Stock |
|
|
|
|
|
1,475,311 |
02 Jul 2025 |
Direct |
|
| holding |
XMTR |
Class A Common Stock |
|
|
|
|
|
85,582 |
02 Jul 2025 |
See footnote |
F4 |
| holding |
XMTR |
Class A Common Stock |
|
|
|
|
|
324,533 |
02 Jul 2025 |
See footnote |
F5 |
| holding |
XMTR |
Class A Common Stock |
|
|
|
|
|
324,533 |
02 Jul 2025 |
See footnote |
F6 |
| holding |
XMTR |
Class A Common Stock |
|
|
|
|
|
324,533 |
02 Jul 2025 |
See footnote |
F7 |
| holding |
XMTR |
Class A Common Stock |
|
|
|
|
|
631,270 |
02 Jul 2025 |
See footnote |
F8 |
| holding |
XMTR |
Class A Common Stock |
|
|
|
|
|
475,248 |
02 Jul 2025 |
See footnote |
F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: